We're exciting young minds with the real world possibilities of science.
Working with Comic Relief to fight malaria
Helping to save one million children's lives
Finding new ways of tackling disease
Helping the most vulnerable communities
Working with partners to discover the medicines of the future
At GSK we’re at the forefront of researching new ways to tackle some of the world’s biggest healthcare challenges.
10 years from now - how will we fight disease?
Bloomberg TV: Sir Andrew Witty, CEO, GSK, discusses antibiotic resistance in Davos
Bioelectronics at SXSW 2016
SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.
Harnessing the electrical language of the body to treat disease
Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.
Turning the tide on antibiotic resistance
Turning the tide on antibiotic resistance.
GSK’s Patrick Vallance on a new generation antibiotics
GSK’s President of Pharmaceutical R&D explains why GSK is involved in challenging antibiotics resistance.
Guardian article: Igniting a revolution in scientific research and development
Innovative partnerships between science, business and charities could help tackle some of the most challenging healthcare issues, transforming the prospects of developing countries.
GSK’s President of Pharmaceutical R&D discusses the challenges of discovering new medicines on BBC Radio 4
Patrick Vallance is something of a rare breed: a game-keeper turned poacher; an academic who's moved over into industry. And not just any industry, but the pharmaceutical industry.
GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease
Working towards the development of bioelectronic medicines